Jonathan D. Root - 10 Jun 2024 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
Director
Signature
/s/ John R. Moore Attorney-in-Fact for Jonathan Root M.D.
Issuer symbol
EWTX
Transactions as of
10 Jun 2024
Net transactions value
$0
Form type
4
Filing time
12 Jun 2024, 19:22:48 UTC
Previous filing
26 Apr 2024
Next filing
19 Feb 2025
SEC
View on sec.gov

Quoteable Key Fact

"Jonathan D. Root filed Form 4 for Edgewise Therapeutics, Inc. (EWTX) on 12 Jun 2024."

Quick Takeaways

  • This page summarizes Jonathan D. Root's Form 4 filing for Edgewise Therapeutics, Inc. (EWTX).
  • 1 reported transaction and 1 derivative row are listed below.
  • Filing timestamp: 12 Jun 2024, 19:22.

What Changed

  • Previous filing in this sequence was filed on 26 Apr 2024.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Source Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EWTX Stock Option (Right to Buy) Award $0 +20,594 $0.000000 20,594 10 Jun 2024 Common Stock 20,594 $17.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the Stock Options granted on June 10, 2024 will become vested on the earlier of (i) June 10, 2025 or (ii) the business day prior to the date of the 2025 annual meeting of stockholders.